Article
Biochemistry & Molecular Biology
Yukiko Yamashita, Keigo Gohda, Yusuke Iguchi, Ko Fujimori, Keisuke Oda, Arisa Masuda, Mizuho Une, Naoki Teno
Summary: This study identified a benzimidazole compound 18 with dual partial agonistic activity for FXR and PPAR gamma, which could be a novel candidate for treating NAFLD associated with type 2 diabetes mellitus.
BIOORGANIC & MEDICINAL CHEMISTRY
(2023)
Article
Medicine, General & Internal
Xiaomeng Feng, Xia Gao, Shuo Wang, Mengxiu Huang, Zhencheng Sun, Hengbei Dong, Haitian Yu, Guang Wang
Summary: The study showed that PPAR-alpha agonist fenofibrate prevents diabetic nephropathy in type 2 diabetic mouse kidneys by regulating endothelial cell function, reducing recruitment of M1 macrophages, and inhibiting the HIF-1 alpha/Notch1 pathway.
FRONTIERS IN MEDICINE
(2021)
Article
Pharmacology & Pharmacy
Sujuan Guan, Tingting Hu, Liushan Chen, Zheng Li, Zhenming Lin, Jinping Lei, Juan Shen
Summary: PPARβ/FFA1 dual agonist Y8 promotes the healing of diabetic ulcer wounds in vivo and in vitro. It accelerates wound healing and reduces healing time in diabetic mice. Mechanistically, Y8 activates PPARβ to promote keratinocyte proliferation and activates FFA1 to enhance keratinocyte migration. Y8 also decreases ROS levels in fibroblasts by activating PPARβ.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2023)
Article
Chemistry, Medicinal
Xiangbao Meng, Yuan Zhang, Zongyang Li, Jinxian Hu, Di Zhang, Weiwei Cao, Min Li, Guoxu Ma, Sicen Wang, Ping Cui, Qian Cai, Guodong Huang
Summary: This study suggests that Gypenoside LXXV (GP-75) from Gynostemma pentaphyllum may be a novel PPAR gamma agonist that has the potential to improve diabetes-associated cognitive decline. GP-75 treatment enhances brain glucose uptake, improves glucose tolerance and lipid metabolism, and suppresses neuroinflammation, leading to attenuation of cognitive deficits.
PHYTOTHERAPY RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Bin Xiao, Dan-dan Li, Ying Wang, Eun La Kim, Na Zhao, Shang-Wu Jin, Dong-Hao Bai, Li-Dong Sun, Jee H. Jung
Summary: Molecular docking identified parecoxib as a potential PPAR-γ agonist, inducing adipocyte differentiation and enhancing adipogenesis in a dose-dependent manner. It may be utilized for drug repositioning studies as a partial PPAR-γ agonist.
BIOMOLECULES & THERAPEUTICS
(2021)
Article
Chemistry, Medicinal
Zheng Li, Qiang Ren, Zongtao Zhou, Zongyu Cai, Bin Wang, Jing Han, Luyong Zhang
Summary: A new dual PPAR δ/γ partial agonist, ZLY06, was identified and showed excellent pharmacokinetic profiles suitable for oral medication, significantly improving glucolipid metabolism without causing weight gain or hepatic steatosis. This study suggests potential benefits of ZLY06 on metabolic syndrome with no adverse effects related to commonly used PPAR γ full agonist.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Dohee Ahn, Jinsoo Kim, Gibeom Nam, Xiaodi Zhao, Jihee Kwon, Ji Young Hwang, Jae Kwan Kim, Sun-Young Yoon, Sang J. Chung
Summary: The coexistence of type 2 diabetes and obesity, known as diabesity, has led to the exploration of potential therapeutic agents. In this study, ethyl gallate was discovered to be a selective inhibitor of PTPN6 and a potent antagonist of PPAR gamma. It showed promising effects in suppressing adipogenesis and promoting glucose uptake, making it a potential candidate for diabesity treatment.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Pharmacology & Pharmacy
Amit Joharapurkar, Vishal Patel, Samadhan Kshirsagar, Maulik S. Patel, Hardikkumar Savsani, Mukul Jain
Summary: Saroglitazar showed significant benefits in reducing retinal vascular damage in diabetic rats, as well as in decreasing neovascularization in oxygen-induced retinopathy and VEGF-induced angiogenesis.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Article
Nutrition & Dietetics
Xiaodi Zhao, Dohee Ahn, Gibeom Nam, Jihee Kwon, Songyi Song, Min Ji Kang, Hyejin Ahn, Sang J. Chung
Summary: This study identifies crocetin as the active component of saffron, functioning as a GPR40/120 agonist with potential implications in antidiabetic interventions.
Article
Plant Sciences
Amanda de Assis Carneiro, Simone Batista Pires Sinoti, Marcela Medeiros de Freitas, Luiz Alberto Simeoni, Christopher William Fagg, Perola de Oliveira Magalhaes, Damaris Silveira, Yris Maria Fonseca-Bazzo
Summary: Inhibition of systemic inflammation is beneficial for treating non-communicable diseases, and the hydroethanolic extract of M. nigra leaves can activate PPAR and promote anti-inflammatory effects. The extract contains rutin and isoquercitrin as major compounds and reduces the production of ROS, NO, and TNF-alpha.
Article
Chemistry, Analytical
Reza E. Rad, Arash Hejazi, Seyed-Ali H. Asl, Khuram Shehzad, Deeksha Verma, SungJin Kim, Behnam S. Rikan, YoungGun Pu, Joon Tae Kim, Keum Cheol Hwang, Youngoo Yang, Kang-Yoon Lee
Summary: This paper introduces an analog front-end for fine-dust detection systems with high sensitivity and a wide dynamic range. The front end consists of a TIA, DCOC, SDA, and two PGAs, and features both coarse and fine gain adjustment steps. Experimental results demonstrate high gain operation and minimal detectable current signal for this front-end.
Article
Pharmacology & Pharmacy
Sergio Hidalgo-Figueroa, Ana Rodriguez-Luevano, Julio C. Almanza-Perez, Abraham Giacoman-Martinez, Rolffy Ortiz-Andrade, Ismael Leon-Rivera, Gabriel Navarrete-Vazquez
Summary: The manuscript describes the design of two molecules targeting PPAR gamma and GPR40 receptors, with compound 1 showing strong activity in increasing mRNA expression levels of PPAR gamma, GLUT4, and GPR40. Additionally, compound 1 exhibited a moderate increase in insulin secretion and calcium mobilization. These findings suggest that compound 1 acts as a dual PPAR gamma and GPR40 agonist, offering better glycemic control than current treatments.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Article
Chemistry, Medicinal
Kai Liu, Xing Zhao, Xue Qi, Dong-Liang Hou, Hao-Bin Li, Yu-Hao Gu, Qing-Long Xu
Summary: The study designed and synthesized a novel dual PPAR-α/Δ agonist, compound 12, which showed high activity and selectivity against PPAR-γ, holding therapeutic promise for DKD by inhibiting inflammatory processes through JNK/NF-kappa B pathways.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2021)
Article
Biochemistry & Molecular Biology
Luiz A. Dutra, Mariella G. Lacerda, Maiara Destro Inacio, Johnny W. L. Martins, Ana C. Lopes Silva, Patricia Bento da Silva, Marlus Chorilli, Angelica A. Amato, Amanda M. Baviera, Marisa Passarelli, Rafael V. C. Guido, Jean L. Dos Santos
Summary: Peroxisome proliferator-activated receptors (PPARs) are potential therapeutic targets for metabolic diseases, and this study focuses on the design and synthesis of stilbene-based compounds as dual PPAR alpha/gamma partial agonists. The lead compound 5b showed promising effects in removing cholesterol from foam cells and improving lipid levels, insulin sensitivity, and glucose levels in an obesity mouse model.
BIOORGANIC CHEMISTRY
(2022)
Article
Chemistry, Medicinal
Antonio Laghezza, Carmen Cerchia, Massimo Genovese, Rosalba Leuci, Erica Pranzini, Alice Santi, Leonardo Brunetti, Luca Piemontese, Paolo Tortorella, Abanish Biswas, Ravi Pratap Singh, Suhas Tambe, Sudeep Ca, Ashok Kumar Pattnaik, Venkatesan Jayaprakash, Paolo Paoli, Antonio Lavecchia, Fulvio Loiodice
Summary: A new ligand 10 was identified, which can potently activate both PPAR alpha and -gamma subtypes as full and partial agonists, respectively. Docking studies were performed to explain the different effects on the two targets. In vivo experiments showed that compound 10 significantly reduced blood glucose and lipid levels in diabetic mouse models without toxic effects, and further investigation revealed its inhibitory effect on the mitochondrial pyruvate carrier, suggesting its potential for treating dyslipidemic type 2 diabetes as a new class of drugs.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Review
Pharmacology & Pharmacy
Ishaq N. Khan, Saleh Al-Karim, Roop S. Bora, Adeel G. Chaudhary, Kulvinder S. Saini
DRUG DISCOVERY TODAY
(2015)
Review
Biotechnology & Applied Microbiology
Mohammed N. Baeshen, Ahmed M. Al-Hejin, Roop S. Bora, Mohamed M. M. Ahmed, Hassan A. I. Ramadan, Kulvinder S. Saini, Nabih A. Baeshen, Elrashdy M. Redwan
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
(2015)
Article
Biotechnology & Applied Microbiology
Raziuddin Khan, Mohammed N. Baeshen, Kulvinder S. Saini, Roop S. Bora, Ahmed M. Al-Hejin, Nabih A. Baeshen
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
(2016)
Article
Biotechnology & Applied Microbiology
Mohammed N. Baeshen, Thamer A. F. Bouback, Mubarak A. Alzubaidi, Roop S. Bora, Mohammed A. T. Alotaibi, Omar T. O. Alabbas, Sultan M. Alshahrani, Ahmed A. M. Aljohani, Rayan A. A. Munshi, Ahmed Al-Hejin, Mohamed M. M. Ahmed, Elrashdy M. Redwan, Hassan A. I. Ramadan, Kulvinder S. Saini, Nabih A. Baeshen
BIOMED RESEARCH INTERNATIONAL
(2016)
Article
Cardiac & Cardiovascular Systems
Jitendra S. Kanshana, Vivek Khanna, Vishal Singh, Manish Jain, Ankita Misra, Sachin Kumar, Mariya Farooqui, Manoj K. Barthwal, Madhu Dikshit
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
(2017)
Article
Plant Sciences
Jitendra S. Kanshana, Sanjay C. Rebello, Priya Pathak, Babu Nageswararao Kanuri, Hobby Aggarwal, Vasundhara Srivastava, Vivek Khanna, Vishal Singh, Kumaravelu Jagavelu, Manoj K. Barthwal, Madhu Dikshit
JOURNAL OF ETHNOPHARMACOLOGY
(2018)
Review
Public, Environmental & Occupational Health
Waseem Mohammed Abdul, Nahid H. Hajrah, Jamal S. M. Sabir, Saleh M. Al-Garni, Meshaal J. Sabir, Saleh A. Kabli, Kulvinder Singh Saini, Roop Singh Bora
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
(2018)
Article
Pharmacology & Pharmacy
Prem Prakash, Vishal Singh, Manish Jain, Minakshi Rana, Vivek Khanna, Manoj Kumar Barthwal, Madhu Dikshit
EUROPEAN JOURNAL OF PHARMACOLOGY
(2014)
Article
Cardiac & Cardiovascular Systems
Amit Manhas, Vivek Khanna, Prem Prakash, Dipika Goyal, Richa Malasoni, Arshi Naqvi, Anil K. Dwivedi, Madhu Dikshit, Kumaravelu Jagavelu
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
(2014)
Article
Oncology
Waqas Iqbal, Saleh Alkarim, Tahseen Kamal, Hani Choudhry, Jamal Sabir, Roop S. Bora, Kulvinder S. Saini
INTEGRATIVE CANCER THERAPIES
(2018)
Article
Biotechnology & Applied Microbiology
Nahid Hassan Hajrah, Waseem Mohammed Abdul, Saleh Mohammed Al-Garni, Abdullah Sheikh, Mohamed Morsi Mohamed Ahmed, Neil Hall, Kulvinder Singh Saini, Jamal Sabir Mohammad Sabir, Roop Singh Bora
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
(2019)
Article
Agriculture, Multidisciplinary
Mohamed Morsi M. Ahmed, Md Mohibul Alam Khan, Saleh M. S. Al-Garni, Roop Singh Bora, Saleh A. Kabli
BIOSCIENCE JOURNAL
(2020)
Article
Public, Environmental & Occupational Health
Meena Verma, Roop Singh Bora, Imran Sheikh, Vinod Kumar, Punesh Sangwan, Harcharan Singh Dhaliwal
Summary: The study found that gibberellins and ascorbic acid can significantly reduce phytic acid content in wheat flour, increase the dialyzability of iron and zinc, and improve the micronutrient content in wheat grains.
INDIAN JOURNAL OF COMMUNITY HEALTH
(2021)
Article
Chemistry, Multidisciplinary
Abdullah Y. Obaid, Sreedhara Voleti, Roop Singh Bora, Nahid H. Hajrah, Abdulkader M. Shaikh Omer, Jamal S. M. Sabir, Kulvinder Singh Saini
CHEMISTRY CENTRAL JOURNAL
(2017)
Article
Oncology
Nahid H. Hajrah, Waseem Mohammed Abdul, Zainab H. Abdul-Hameed, Walied M. Alarif, Nouf Saeed A. Al-Abbas, Seif-Eldin N. Ayyad, Abdulkader M. Shaikh Omer, Mohammed Zainy Mutawakil, Neil Hall, Abdullah Y. Obaid, Roop Singh Bora, Jamal S. M. Sabir, Kulvinder Singh Saini
INTEGRATIVE CANCER THERAPIES
(2020)